{
    "root": "35ac564a-d6b8-507d-e063-6394a90a489a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "topiramate",
    "value": "20250521",
    "ingredients": [
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "TOPIRAMATE",
            "code": "0H73WJJ391"
        }
    ],
    "indications": "topiramate indicated : epilepsy : initial monotherapy treatment partial-onset primary generalized tonic-clonic seizures patients 2 years age older ( 1.1 ) ; adjunctive therapy treatment partial-onset seizures , primary generalized tonic-clonic seizures , seizures associated lennox-gastaut syndrome patients 2 years age older ( 1.2 ) preventive treatment migraine patients 12 years age older ( 1.3 )",
    "contraindications": "topiramate initial dose , titration , recommended maintenance dose varies indication age group . full prescribing information recommended , dosing considerations patients renal impairment , geriatric patients , patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions": "store 20 25 c ( 68 77 f ) [ usp controlled room temperature ] . protect moisture . dispense tight container . topiramate tablets usp , 50 mg white off-white , round-shaped , biconvex , beveled-edge , film-coated tablets debossed `` zd 15 `` one side plain side supplied follows : ndcs 60760-577-90 bottle 90 60760-577-60 bottle 60",
    "adverseReactions": "none ( 4 )",
    "indications_original": "Topiramate is indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 ); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2 ) Preventive treatment of migraine in patients 12 years of age and older ( 1.3 )",
    "contraindications_original": "Topiramate initial dose, titration, and recommended maintenance dose varies by indication and age group. See Full Prescribing Information for recommended dosage, and dosing considerations in patients with renal impairment, geriatric patients, and patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions_original": "Store at 20 o to 25 o C (68 o to 77 o F) [See USP Controlled Room Temperature]. Protect from moisture.\n                  Dispense in a tight container.\n                  Topiramate Tablets USP, 50 mg are white to off-white, round-shaped, biconvex, beveled-edge, film-coated tablets debossed with \"ZD 15\" on one side and plain on the other side and are supplied as follows:\n                  NDCs\n  \n                     \n60760-577-90 BOTTLE OF 90\n \n                  \n                  60760-577-60 BOTTLE OF 60",
    "adverseReactions_original": "None ( 4 )"
}